Skip to content
World Health Systems Facts

Germany: Health System Outcomes

Germany: Health System Outcomes

German Health System Overview
Health System Rankings
Outcomes
Health System Coverage
Costs for Consumers
Health System Expenditures
Germany’s COVID-19 Strategy

Health System Financing
Medical Personnel
Health System Physical Resources and Utilization
Long-Term Care
Medical Training
Health Information and Communications Technologies
Pharmaceuticals

Political System
Economic System
Population Demographics
People With Disabilities
Aging
Social Determinants & Health Equity
Health System History
Health System Challenges


Life Expectancy at Birth (2019): 81.7
Maternal Mortality Ratio (per 100,000 live births) (2017): 7
Neonatal Mortality Rate (per 1,000 live births) (2020): 2
Probability of Dying from any of Cardiovascular Disease, Cancer, Diabetes, Chronic Respiratory Diseases Between Age 30 and Exact Age 70 (%) (2019): 12.1%

Source: World health statistics 2022: monitoring health for the SDGs, sustainable development
goals
. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.


Neonatal Mortality Rate (Deaths Per 1,000 Live Births) (2019): 2
Infant Mortality Rate (Deaths Per 1,000 Live Births) (2019): 3
Under-5 Mortality Rate (Deaths Per 1,000 Live Births) (2019):
  Male: 4; Female: 3

Note: “Under-5 mortality rate – Probability of dying between birth and exactly 5 years of age, expressed per 1,000 live births.
“Infant mortality rate – Probability of dying between birth and exactly 1 year of age, expressed per 1,000 live births.
“Neonatal mortality rate – Probability of dying during the first 28 days of life, expressed per 1,000 live births.”

Source: United Nations Children’s Fund, The State of the World’s Children 2021: On My Mind – Promoting, protecting and caring for children’s mental health, UNICEF, New York, October 2021.


Adverse events in hip and knee surgeries: post-operative pulmonary embolism (PE) or deep vein thrombosis (DVT), 2019 (Rate per 100,000 Discharges):
— PE: 347.2; DVT: 329
Obstetric trauma, vaginal delivery with and without instrument, 2019 (Crude rate per 100,000 hospital discharges):
— With Instrument: 1.5; Without Instrument: 6.6
Asthma hospital admission in adults, 2019 (Age-sex standardized rates per 100,000 population): 31.5
Chronic obstructive pulmonary disorder (COPD) hospital admission in adults, 2019 (Age-sex standardized rates per 100,000 population): 249.6
Congestive heart failure (CHF) hospital admission in adults, 2019 (Age-sex standardized rates per 100,000 population): 393.3
Diabetes hospital admission in adults, 2019 (Age-sex standardized rates per 100,000 population): 206.1

Source: OECD (2021), Health at a Glance 2021: OECD Indicators, OECD Publishing, Paris, https://doi.org/10.1787/ae3016b9-en.


“Life expectancy at birth in Germany has increased by almost three years since 2000 (from 78.3 years to 81.1 years in 2020), but most of this gain occurred between 2000 and 2010, and the increase was only eight months between 2010 and 2019. Most other EU Member States achieved greater progress in life expectancy during this period – particularly countries in the central and eastern part of Europe, as well as Denmark and Ireland. As with most other EU countries, life expectancy showed a temporary decrease between 2019 and 2020 owing to the impact of the COVID-19 pandemic: in Germany, this reduction was 2.5 months compared to an EU average of nearly 8.5 months. German life expectancy is now half a year above the EU average (Figure 1) but still around 1.5 years lower than the rate in EU countries with the highest levels.

“A substantial gender gap in life expectancy persists in Germany: women can expect to live 4.7 years longer than men (83.7 compared to 79 years), but this gap is slightly smaller than the EU average (5.6 years).”

Source: OECD/European Observatory on Health Systems and Policies (2021), Germany: Country Health Profile 2021, State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels.


“Life expectancy at birth in Germany has increased by 2.7 years since 2000 and reached 81.0 years in 2018 (Table 1.3). Although life expectancy is slightly above the EU average of 80.9 years, it has increased more slowly than in most other EU countries since 2000 and is lower than in all other western European countries (OECD/European Observatory on Health Systems and Policies, 2019). As in other countries there is a gender gap in life expectancy and women born in 2018 are expected to live on average 4.7 years longer than men. The gender gap in life expectancy has narrowed by 1.4 years since 2000. Life expectancy after the age of 65 increased from 15.8 to 18.0 years for men and from 19.6 to 21.1 years for women between 2000 and 2018, i.e. the gender gap has narrowed in the elderly as well (Table 1.3).”

Source: Blümel M, Spranger A, Achstetter K, Maresso A, Busse R. Germany: Health system review. Health Systems in Transition, 2020; 22(6): pp.i–273.


“Table 1.3 shows that the total mortality rate in Germany has been steadily declining since 2000. This positive development is also reflected in the increases seen in life expectancy at birth. According to Eurostat data, the standardized death rate (SDR) for all causes of death was higher than the EU average in 2016 (1017 in Germany compared to 998 per 100,000 population across the EU), with the relative difference being smaller for younger people compared to older ones, and for men compared to women. The two most common causes of death by far in Germany in 2017 were diseases of the circulatory system (accounting for 37% of all deaths) and malignant neoplasms (cancers) (24%), followed by diseases of the respiratory system (7%), Alzheimer’s and other dementias (5%), and diseases of the digestive system (4%).

“Diseases of the circulatory system have decreased sharply since 2000, mostly attributable to the decline in mortality caused by ischaemic heart disease. In 2000 there were 248 deaths per 100,000 population due to ischaemic heart diseases with a considerably higher mortality rate among males (SDR 334 per 100,000 population) than among females (SDR 195 per 100,000 population). While this mortality rate decreased by 44% for both genders (to 139 per 100,000 population), 40% for men (to 199 per 100,000 population) and 50% for women (to 98 per 100,000 population) up to 2017, it is still considerably higher than the EU average (162 males and 86 females per 100,000 population).

“Mortality due to malignant neoplasms also decreased over this period, particularly with regard to cervical and breast cancer. Lung cancer is the most frequent cause of cancer deaths, accounting for 20% of all cancer deaths. While lung cancer mortality has decreased in men by 9% since 2009, this indicator has increased in woman by 20%, mainly due to changes in smoking habits (see below). Diseases of the respiratory system are the third leading cause of death. While the mortality rate is considerably higher in males (100 per 100,000 population) than females (54 per 100,000 population), it is lower than the EU average as a whole and for both genders.

“Strikingly, an increase of 76% can be observed in the age-standardized death rates for Alzheimer’s and other dementias for both genders since 2010. However, this rise reflects both the ageing German population and improved identification and recording of these diseases as causes of death.”

Source: Blümel M, Spranger A, Achstetter K, Maresso A, Busse R. Germany: Health system review. Health Systems in Transition, 2020; 22(6): pp.i–273.


“A measure to assess the contribution of health care to population health is the concept of “amenable mortality”. Amenable mortality reflects premature deaths that should not occur in the presence of timely and effective health care. Based on the WHO mortality database, amenable mortality has declined in all EU countries since 2000, albeit to varying degrees. In Germany the amenable mortality rate decreased from 131.5 deaths per 100,000 population in 2000 to 81.8 deaths per 100 000 population in 2017 (Figure 7.7), but it still accounts for 23.3% of total mortality under the age of 75 and for both sexes combined (Eurostat, 2019). Amenable mortality in Germany is significantly lower than the EU average (122.4 deaths per 100,000 population), but higher than in the selected neighbouring countries Switzerland (50.9), France (57.3), the Netherlands (63.2), Austria (71.7) and Denmark (74.7) (Figure 7.7).

“Another measure to assess health that may be attributed to the health system is the indicator “preventable mortality”. This concept includes deaths which could have been avoided by public health interventions focusing on the wider determinants of public health, such as behaviour and lifestyle factors, socioeconomic status and environmental factors as well. In 2017 Germany could have prevented 51.3 deaths per 100,000 population through effective public health interventions, compared to 68.6 in 2000 (-25.2%). Again, Germany performs better than the EU average (56.1 per 100,000 population), but preventable mortality is higher than in the selected neighbouring countries Switzerland (34.9), the Netherlands (45.3), Austria (48.9) and France (49.9), and is only lower than in Denmark (54.5 per 100,000 population) (Figure 7.7).

“Eurostat data differ slightly from the WHO mortality database – due to differences in how amenable and preventable mortality are conceptualized – and are estimated at 154.8 preventable deaths per 100,000 population and 85.8 amenable deaths per 100,000 population in 2017. Compared to the selected neighbouring countries, Germany has the highest number of amenable deaths and the third highest preventable mortality rate in 2017 (Figure 7.8). Looking at the causes of amenable mortality, ischemic heart disease is the main driver in Germany, accounting for 22% of all amenable deaths in 2017 (18.9 per 100,000 population), followed by colorectal cancer (14.9% or 12.8 per 100 000 population), breast cancer (13.1% or 11.2 per 100,000 female population), stroke (7.9% or 6.8 per 100,000 population), pneumonia (4.6% or 4.0 per 100,000 population) and diabetes (4.4% or 3.8 per 100,000 population) (Eurostat, 2020a). Lung cancer is the leading cause of preventable mortality in Germany. In 2017 there were 34.8 deaths per 100,000 population, making lung cancer responsible for 28.3% of all preventable deaths. Among the comparator countries, this rate is higher in France (35.7 per 100,000 population), Denmark (38.6 per 100,000 population) and the Netherlands (39.1 per 100,000 population). Ischemic heart disease, which causes both amenable and preventable mortality, is the second leading cause (22% or 18.9 per 100,000 population), followed by alcohol-related diseases (9.8% or 15.2 per 100,000 population), and chronic lower respiratory diseases (10.5% or 16.2 per 100,000 population) (Figure 7.8).”

Source: Blümel M, Spranger A, Achstetter K, Maresso A, Busse R. Germany: Health system review. Health Systems in Transition, 2020; 22(6): pp.i–273.


Health Systems Facts is a project of the Real Reporting Foundation. We provide reliable statistics and other data from authoritative sources regarding health systems in the US and sixteen other nations.


Page last updated Jan. 25, 2023 by Doug McVay, Editor.

  • Home
  • About Health Systems Facts
    • Contact Us
    • Join Our Email List
  • Breaking News & Opinion
  • Upcoming Events
  • Seventeen National Health Systems
    • Austria
    • Canada
    • Costa Rica
    • Czech Republic
    • Denmark
    • France
    • Germany
    • Hungary
    • Italy
    • Japan
    • Netherlands
    • South Korea
    • Spain
    • Sweden
    • Switzerland
    • United Kingdom
    • United States
  • Comparing National Health Systems
    • Healthcare Access and Quality Index
    • Sustainable Development Goals Health Index
    • Mirror Mirror 2021
    • World Health Report 2000
    • International Health Systems In Perspective
    • Lessons for US Health Reform
  • Aging
  • Health System Outcomes
  • Healthcare Spending
  • Healthcare Workers
    • Health System Personnel
    • Health Workforce Training
  • Information and Communications Technologies
  • Long-Term Services and Supports
  • People With Disabilities
  • Pharmaceutical Pricing and Regulation
  • Social Determinants Of Health
  • Wasteful Spending
  • Various US Health System Proposals
    • Affordable Care Act
    • All Payer
    • Public Option
    • Single Payer / “Medicare For All”
    • Universal Health Coverage
  • Recommended Resources
  • Privacy Policy
    • Cookie Policy
  • Facebook
  • LinkedIn
  • Twitter

© 2019-2022 Real Reporting Foundation | Theme by WordPress Theme Detector

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
_GRECAPTCHA5 months 27 daysThis cookie is set by Google. In addition to certain standard Google cookies, reCAPTCHA sets a necessary cookie (_GRECAPTCHA) when executed for the purpose of providing its risk analysis.
cookielawinfo-checkbox-advertisement1 yearThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertisement".
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThis cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
_gat_UA-71314304-21 minuteThis is a pattern type cookie set by Google Analytics, where the pattern element on the name contains the unique identity number of the account or website it relates to. It appears to be a variation of the _gat cookie which is used to limit the amount of data recorded by Google on high traffic volume websites.
_gcl_au3 monthsThis cookie is used by Google Analytics to understand user interaction with the website.
_gid1 dayThis cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visted in an anonymous form.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
CookieDurationDescription
IDE1 year 24 daysUsed by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
test_cookie15 minutesThis cookie is set by doubleclick.net. The purpose of the cookie is to determine if the user's browser supports cookies.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT
Powered by CookieYes Logo